NASP Comments to CMS on Part B Drug Proposal

NASP Comments to CMS on Part B Drug Proposal

NASP comments on the organization’s concerns over the CMS proposed plan.

 Download PDF for details.

We’ve updated our privacy policy, including to provide further detail about how we collect, protect, use, and share personal data. Click here to view the privacy policy.

Top